Summit Therapeutics (SMMT) Market Capitalization Overview

2 days ago · As of Jan 14, 2025, Summit Therapeutics (SMMT) has a market capitalization of $12.28B.Over the past 30 days, its market cap has decreased by -0.76%, while in the last 12 months, it has decreased by -6.7%. Market capitalization represents the total value of Summit …

76%
OFF

Summit Therapeutics (SMMT) Market Capitalization Overview

2 weeks from now

public.com

€12.50
OFF

Summit Therapeutics (SMMT) - Market Capitalization

2 weeks from now

Market capitalization of Summit Therapeutics (SMMT) Market cap: €12.50 Billion As of December 2024 Summit Therapeutics has a market cap of €12.50 Billion.This makes Summit …

companiesmarketcap.com

$13.40
OFF

Summit Therapeutics Stock Price Today (NASDAQ: SMMT) Quote, …

2 weeks from now

2 days ago · (NASDAQ: SMMT) Summit Therapeutics's market cap is $13.40B, as of Jan 14, 2025. Market cap (market capitalization) is the total market value of a publicly traded …

wallstreetzen.com

$12.28
OFF

Summit Therapeutics (NASDAQ:SMMT) Trading Down 6.3

2 weeks from now

2 days ago · Summit Therapeutics Stock Performance. The company has a market cap of $12.28 billion, a price-to-earnings ratio of -59.46 and a beta of -0.87. The company's 50 day moving …

marketbeat.com

£10.82
OFF

Summit Therapeutics (SMMT) - Market Capitalization

2 weeks from now

Market capitalization of Summit Therapeutics (SMMT) Market cap: £10.82 Billion As of January 2025 Summit Therapeutics has a market cap of £10.82 Billion.This makes Summit …

companiesmarketcap.com

584%
OFF

Why Summit Therapeutics Rocketed 584% In 2024 - Yahoo Finance

2 weeks from now

1 day ago · Shares of biotech Summit Therapeutics (NASDAQ: SMMT) skyrocketed 583.7% in 2024, according to data from S&P Global Market Intelligence. Summit was an early-stage …

yahoo.com

$20
OFF

The Play On Summit Therapeutics (NASDAQ:SMMT) - Seeking Alpha

2 weeks from now

Jan 5, 2025 · A $20+ billion market cap for a clinical-stage concern ... Company Overview: Summit Therapeutics, Inc. is a Miami, Florida based clinical-stage biopharmaceutical concern …

seekingalpha.com

584%
OFF

Why Summit Therapeutics Rocketed 584% In 2024 | The Motley Fool

2 weeks from now

1 day ago · Market Cap. $13B. Today's Change (9.31%) $1.55 ... $18.20. Price as of January 15, 2025, 4:00 p.m. ET. Shares of biotech Summit Therapeutics (SMMT ... according to data from …

fool.com

$18.82
OFF

Summit Therapeutics (NASDAQ:SMMT) Coverage Initiated By

2 weeks from now

Jan 8, 2025 · The stock has a fifty day moving average of $18.82 and a two-hundred day moving average of $16.36. Summit Therapeutics has a fifty-two week low of $2.10 and a fifty-two …

marketbeat.com

$35
OFF

Summit Therapeutics Initiated With A Buy At Truist

2 weeks from now

Jan 8, 2025 · Truist initiated coverage of Summit Therapeutics (SMMT) with a Buy rating and $35 price target Summit is a biotech company built around ivonescimab, the most clinically …

businessinsider.com

$169000
OFF

7100 Boulevard East APT 11K, Guttenberg, NJ 07093 - Zillow

2 weeks from now

Dec 23, 2024 · Zillow has 38 photos of this $169,000 1 bed, 1 bath, 700 Square Feet condo home located at 7100 Boulevard East APT 11K, Guttenberg, NJ 07093 MLS #240008148.

zillow.com

584%
OFF

Why Summit Therapeutics Rocketed 584% In 2024 - MSN

2 weeks from now

Shares of biotech Summit Therapeutics (NASDAQ: SMMT) skyrocketed 583.7% in 2024, according to data from S&P Global Market Intelligence. Summit was an early-stage …

msn.com

$18.60
OFF

Summit Therapeutics (SMMT) - Market Capitalization

2 weeks from now

Market capitalization of Summit Therapeutics (SMMT) Market cap: C$18.60 Billion As of January 2025 Summit Therapeutics has a market cap of C$18.60 Billion.This makes Summit …

companiesmarketcap.com

$18.42
OFF

Summit Therapeutics (SMMT) - Market Capitalization

2 weeks from now

Market capitalization of Summit Therapeutics (SMMT) Market cap: S$18.42 Billion As of January 2025 Summit Therapeutics has a market cap of S$18.42 Billion.This makes Summit …

companiesmarketcap.com

FAQs about Summit Therapeutics (SMMT) Market Capitalization Overview Coupon?

What happened to Summit Therapeutics (SMMT) shares in 2024?

Shares of biotech Summit Therapeutics(NASDAQ: SMMT) skyrocketed 583.7% in 2024, according to data from S&P Global Market Intelligence. ...

Should you buy Summit Therapeutics (SMMT)?

Truist initiated coverage of Summit Therapeutics (SMMT) with a Buy rating and $35 price target Summit is a biotech company built around ivonescimab, the most clinically advanced asset in a novel class of drugs that has potential to surpass the most successful drug class in oncology, the analyst tells investors in a research note. ...

Is Summit Therapeutics a good stock to buy?

Summit's financial health is bolstered by significant investments and private placements, providing a decent operating runway with ongoing and planned NSCLC trials. An analysis around Summit Therapeutics and how I am placing a trade on this stock is highlighted in the paragraphs below. Looking for a helping hand in the market? ...

Why are Summit Therapeutics shares down 40%?

Learn More » Bill Oxford Shares of oncology concern Summit Therapeutics, Inc. (NASDAQ:SMMT)are down over 40% since achieving an all-time closing high in September 2024 after specifics on its Keytruda-beating therapy were announced. ...